US Stock MarketDetailed Quotes

ACON Aclarion

Watchlist
  • 0.2995
  • +0.0026+0.88%
Close Apr 19 16:00 ET
  • 0.2899
  • -0.0096-3.21%
Post 17:08 ET
2.14MMarket Cap-33P/E (TTM)

About Aclarion Company

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Company Profile

SymbolACON
Company NameAclarion
Listing DateApr 22, 2022
Issue Price4.34
Founded2008
CEOMr. Brent Ness
MarketNASDAQ
Employees6
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address8181 Arista Place,Suite 100
CityBroomfield
ProvinceColorado
CountryUnited States of America
Zip Code80021
Phone1-833-275-2266

Company Executives

  • Name
  • Position
  • Salary
  • Brent Ness
  • Chief Executive Officer, President and Director
  • 509.45K
  • Ryan Bond
  • Chief Strategy Officer
  • 219.53K
  • John Lorbiecki
  • Chief Financial Officer and Principal Accounting Officer
  • 334.62K
  • Dr. Jeffrey Thramann, M.D.
  • Executive Chairman of the Board
  • 571.12K
  • David Neal
  • Director
  • 117.24K
  • Amanda Sequira Williams
  • Independent Director
  • 128.35K
  • Dr. Scott Breidbart, M.D.
  • Independent Director
  • 131.80K
  • William G. Wesemann
  • Independent Director
  • 132.77K
  • Steve Deitsch
  • Independent Director
  • 135.25K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg